Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher DeRenzo

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal for Immunotherapy of Cancer|March 14, 2023
CD47 expression is critical for CAR T-cell survival in vivoAlex N Beckett, Peter Chockley, Shondra M Pruett-Miller, et al.
Frontiers in Immunology|July 2, 2021
A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T CellsLindsay Jones Talbot, Ashley Chabot, Amy Funk, et al.
International Journal of Oncology|September 26, 2013
P53 regulates the migration of mesenchymal stromal cells in response to the tumor microenvironment through both CXCL12-dependent and -independent mechanismsSiang-Yo Lin, Sonia C Dolfi, Sohrab Amiri, et al.
Cytotherapy|September 7, 2023
Preparation of cryopreserved chimeric antigen receptor T cells for the locoreogional delivery to the neural axisSalem Akel, Leigh Poston, Jeoungeun J Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2024
Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical ModelsLindsay J Talbot, Ashley Chabot, Aaron B Ross, et al.
Molecular Therapy Oncolytics|July 31, 2020
Route of 41BB/41BBL Costimulation Determines Effector Function of B7-H3-CAR.CD28ζ T CellsPhuong Nguyen, Emmanuel Okeke, Michael Clay, et al.
Advances in Cell and Gene Therapy|April 8, 2021
Engineering Oncolytic Vaccinia Virus to redirect Macrophages to Tumor CellsFelicia Cao, Phuong Nguyen, Bangxing Hong, et al.
Research Square|June 19, 2023
CAR T-cell design dependent remodeling of the brain tumor immune microenvironment identify macrophages as key players that inhibit or promote anti-tumor activityDalia Haydar, Jorge Ibañez-Vega, Jeremy Chase Crawford, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Transcription Factor-Mediated Reprogramming of Cancer-Associated Fibroblasts Reveals Targetable Vulnerabilities in Solid TumorsNan Sook Lee, Priyankan Datta, Yixuan Huang, et al.
Neuro-Oncology|December 15, 2020
Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell deliveryDalia Haydar, Haley Houke, Jason Chiang, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal for Immunotherapy of Cancer|March 14, 2023
CD47 expression is critical for CAR T-cell survival in vivoAlex N Beckett, Peter Chockley, Shondra M Pruett-Miller, et al.
Frontiers in Immunology|July 2, 2021
A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T CellsLindsay Jones Talbot, Ashley Chabot, Amy Funk, et al.
International Journal of Oncology|September 26, 2013
P53 regulates the migration of mesenchymal stromal cells in response to the tumor microenvironment through both CXCL12-dependent and -independent mechanismsSiang-Yo Lin, Sonia C Dolfi, Sohrab Amiri, et al.
Cytotherapy|September 7, 2023
Preparation of cryopreserved chimeric antigen receptor T cells for the locoreogional delivery to the neural axisSalem Akel, Leigh Poston, Jeoungeun J Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2024
Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical ModelsLindsay J Talbot, Ashley Chabot, Aaron B Ross, et al.
Molecular Therapy Oncolytics|July 31, 2020
Route of 41BB/41BBL Costimulation Determines Effector Function of B7-H3-CAR.CD28ζ T CellsPhuong Nguyen, Emmanuel Okeke, Michael Clay, et al.
Advances in Cell and Gene Therapy|April 8, 2021
Engineering Oncolytic Vaccinia Virus to redirect Macrophages to Tumor CellsFelicia Cao, Phuong Nguyen, Bangxing Hong, et al.
Research Square|June 19, 2023
CAR T-cell design dependent remodeling of the brain tumor immune microenvironment identify macrophages as key players that inhibit or promote anti-tumor activityDalia Haydar, Jorge Ibañez-Vega, Jeremy Chase Crawford, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Transcription Factor-Mediated Reprogramming of Cancer-Associated Fibroblasts Reveals Targetable Vulnerabilities in Solid TumorsNan Sook Lee, Priyankan Datta, Yixuan Huang, et al.
Neuro-Oncology|December 15, 2020
Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell deliveryDalia Haydar, Haley Houke, Jason Chiang, et al.
Pageof 3